Evidence map›Paper›PMID 26893849›Full record

ArticleMolecular and clinical oncology2016

Development of combined thymic carcinoma and thymoma in an extrathymic lesion during long follow-up for recurrent thymoma.

Yasuhiro Ohue, Shunichiro Matsuoka, Hirotaka Kumeda, Hiroyuki Agatsuma, Akira Hyougotani, Masayuki Toishi, Takayuki Shiina, Kazuo Yoshida, Kunihiko Shingu, Toshirou Fukushima and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yasuhiro OhueDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Shunichiro MatsuokaDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Hirotaka KumedaDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Hiroyuki AgatsumaDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Akira HyougotaniDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Masayuki ToishiDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Takayuki ShiinaDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Kazuo YoshidaDivision of Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Kunihiko ShinguDepartment of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Toshirou FukushimaDepartment of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Tomonobu KoizumiDepartment of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study reported a rare case of combined thymic squamous cell carcinoma and thymoma exhibiting a mass on the left chest wall. The patient underwent thoracotomy for invasive thymoma 15 years previously, however, suffered a relapse in the left intrathoracic space. Radiotherapy, chemotherapy and partial resection, as secondary surgery for the intrathoracic mass, were performed. The histological findings in the resected specimens revealed type B3 thymoma. As the patient developed a left chest wall mass and pain in 2013, the mass was resected. The histological findings indicated two separate components composed of type B3 thymoma and squamous cell carcinoma. Immunohistological findings revealed that the thymoma cells were positive for CD5, while the thymic carcinoma cells were negative for CD5. Several reports have demonstrated the coexistence of thymic carcinoma and thymoma in the primary thymus, however, the development of a combined tumor in an extrathymic lesion is extremely rare. The present case had a long follow-up for recurrent thymoma. The present case indicated that the development and/or coexistence of malignant components in the thymoma must be taken into consideration for the treatment and/or management of patients with thymoma and that a pre-existence of CD5 expression in thymoma and the lost change may be associated with the process of malignant transformation.

Indexed as

CD5chemotherapyinvasive thymomatacrolimusthymic tumor

Identifiers

PMID26893849
PMCPMC4734238
OpenAlexW2195485395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.